Yahoo Web Search

Search results

    • Analyst Report: argenx SE

      Morningstar Research via Yahoo Finance· 1 day ago

      Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in ...

    • TIME100 Health: Georg Schett

      TIME100 Health: Georg Schett

      Time via Yahoo News· 2 days ago

      Dr. Georg Schett, a rheumatologist at the University Hospital Erlangen in Germany, saw the potential of the treatment for autoimmune diseases like lupus...